Sovremennye aspektyprofilaktiki neytropeniipri khimioterapii solidnykh opukholey

by M E Abramov, L G Zhukova
Published 2010-03-01

Treatment tactics of non-small-cell lung cancer with erlotinib: literature review and description of a clinical case

by E. I. Borisova, S. L. Gutorov, M. E. Abramov
Published 2019-12-01

Ixabepilone: new perspectives for its use in breast cancer

by A. A. Mescheryakov, E. V. Lubennikova, M. E. Abramov
Published 2018-11-01

TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER

by O. O. GORDEEVA, M. E. ABRAMOV, A. N. LUD
Published 2017-06-01

Nab-paclitaxel in the treatment of breast cancer: clinical trial data and first-hand experience

by E. I. Borisova, S. P. Gutorov, G. V. Vyshinskaya, N. V. Dobrova, M. E. Abramov
Published 2018-11-01

The role of erythropoietins in cancer therapy

by O. E. Kondratieva, M. E. Abramov, G. V. Vyshinskaya, S. L. Gutorov, E. I. Borisova, E. V. Cherniglazova
Published 2018-07-01

Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhel...

by L G Zhukova, M E Abramov, Yu V Vakhabova, A N Lud, A A Obukhov, M R Lichinitser
Published 2009-09-01

INFLUENCE OF THE RECOMBINANT TUMOR NECROSIS FACTOR THYMOSIN-α1 ON ANGIOGENESIS IN DISSEMINATED SKIN MELANOMA PATIENTS

by I. A. KOROLEVA, E. G. SLAVINA, A. I. CHERTKOVA, V. A. NURTDINOVA, E. K. SHOUA, M. E. ABRAMOV, Z. G. KADAGIDZE
Published 2017-06-01